Skip to main content
. Author manuscript; available in PMC: 2023 Jun 11.
Published in final edited form as: Am Surg. 2022 Feb 25;89(5):1764–1773. doi: 10.1177/00031348211050816

Table 3.

Multivariable Analysis of Overall Survival of Nonmetastatic Colon Cancer Patients Diagnosed 2010-2015 in the NCDB.

Overall Survival (years from diagnosis)
Covariate Level Hazard ratio (95% CI) HR P-value
Medicaid expansion state Yes .99 (.95-1.03) .570
No
Pathologic stage group 3 3.80 (3.59-4.02) <.001
2 1.85 (1.74-1.97) <.001
1
Median income quartiles 2008-2012 < $38 000 1.21 (1.13-1.29) <.001
$38 000-$47,999 1.12 (1.06-1.19) <.001
$48 000-$62,999 1.11 (1.05-1.17) <.001
≥$63 000
Percent No high school degree 2008-2012 ≥21.0% 1.13 (1.05-1.21) .001
13.0-20.9% 1.21 (1.13-1.29) <.001
7.0-12.9% 1.15 (1.09-1.22) <.001
<7.0%
Year of diagnosis 2015 1.10 (1.02-1.18) .013
2014 1.15 (1.08-1.22) <.001
2013 1.09 (1.02-1.15) .006
2012 1.08 (1.02-1.14) .009
2011 .99 (.94-1.05) .746
2010
Insurance status Government 1.15 (1.08-1.22) <.001
Private .62 (.58-.66) <.001
Not insured
Race Other .82 (.72-.93) .002
Asian .72 (.65-.80) <.001
Black 1.10 (1.05-1.15) <.001
White
Facility type Community cancer program 1.06 (.99-1.13) .112
Comprehensive community cancer program 1.08 (1.02-1.14) .005
Academic/research program .98 (.93-1.04) .564
Integrated network cancer program
Great circle distance >50 miles 1.04 (.98-1.12) .202
10-50 miles .98 (.94-1.01) .206
≤10 miles
Age at diagnosis 1.02 (1.02-1.02) <.001
*

Number of observations in the original data set = 86 413. Number of observations used = 84 775.